Clinical Trial Update: Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or Transplant [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating stereotactic body radiation therapy for unresectable primary liver cancers, including hepatocellular carcinoma, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer | Phase 2 | Status: WITHDRAWN